Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Healthstream (HSTM) Invested Capital (2016 - 2026)

Healthstream has reported Invested Capital over the past 16 years, most recently at $354.0 million for Q4 2025.

  • Quarterly Invested Capital fell 1.48% to $354.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $354.0 million through Dec 2025, down 1.48% year-over-year, with the annual reading at $354.0 million for FY2025, 1.48% down from the prior year.
  • Invested Capital was $354.0 million for Q4 2025 at Healthstream, up from $349.2 million in the prior quarter.
  • Over five years, Invested Capital peaked at $362.8 million in Q1 2025 and troughed at $322.6 million in Q1 2022.
  • The 5-year median for Invested Capital is $341.5 million (2021), against an average of $342.9 million.
  • Year-over-year, Invested Capital dropped 4.23% in 2022 and then increased 5.46% in 2024.
  • A 5-year view of Invested Capital shows it stood at $339.0 million in 2021, then fell by 1.46% to $334.1 million in 2022, then grew by 2.0% to $340.8 million in 2023, then increased by 5.46% to $359.4 million in 2024, then dropped by 1.48% to $354.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Invested Capital are $354.0 million (Q4 2025), $349.2 million (Q3 2025), and $350.6 million (Q2 2025).